The Vanguard for GE is known for its workflow-enhancing 1.5T 8 channel stretcher-based coil solution. This year, Sentinelle is showcasing a significantly expanded line of both stretcher and tabletop-based solutions that address both 1.5T and 3.0T imaging on GE’s Signa(R) HDxt, Discovery(TM) and Optima(TM) MRI platforms that will ship in 2010. The lineup for the Signa(R) HDxt platform will add a 3T 8 channel stretcher and a 1.5T 8 channel tabletop offering. Sentinelle is also excited to introduce high channel count offerings for GE’s new platforms with the 1.5T 16 channel Optima(TM) MR450w stretcher-based coil and the 3.0T 16 channel Discovery(TM) MR750 tabletop coil.
Sentinelle’s Vanguard for Siemens product line is expanded from the current 1.5T 8 channel offerings for the MAGNETOM(R) Espree(TM), MAGNETOM(R) Avanto(TM) and MAGNETOM(R) Symphony, A Tim(TM) System to include both a value and a 3T offering. At RSNA 2009, Sentinelle will be showing the only imaging and interventional breast coil available for the MAGNETOM(R) ESSENZA(TM) platform. This coil has a number of unique features including the ability to perform angled biopsies, allowing clinicians the maximum access to the breast for interventional procedures. The Vanguard for Siemens product line will now include a new 8 channel offering for Siemens 3.0T MAGNETOM(R) Verio(TM) and MAGNETOM(R) Trio(TM) MRIs.
Sentinelle is also excited to add to the current 1.5T Vantage Atlas(TM) and Vantage Titan(TM) Vanguard for Toshiba product line with the new Vantage Titan(TM) 3T**. An offering for the 1.5T Vantage* will also be demonstrated.
In keeping with Sentinelle’s reputation for innovation, a number of new product offerings will be profiled at RSNA 2009. Verity(TM), Sentinelle’s angled biopsy device, enables significantly greater biopsy access over traditional grid-based approaches. Sentinelle will also be demonstrating a new MRI Prostate Imaging and Interventional Suite*. Aegis, Sentinelle’s 4D Advanced Visualization Software Platform, has also been expanded to include a zero footprint Aegis Web option, and new modules enabling a host of new MRI/Ultrasound Navigation* technologies, making the most of its customers’ MRI investment.
“Sentinelle remains focused on delivering clinically relevant products that better enable our customers to manage cancer.” said Cameron Piron, Sentinelle’s President and CEO. “It is rewarding to be able to support our partners and customers with a greatly expanded line of products that will broaden access to these important technologies.”